$DAO

Youdao, Inc. (DAO): Financial results for Q2 2026

Youdao, Inc. (DAO) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 For investor and media inquiries, please contact: In China: Jeffrey Wang Youdao, Inc. Tel: +86-10-8255-8163 ext. 89980 E-mail: IR@rd.netease.com Piacente Financial Communications Helen Wu Tel: +86-10-6508-0677 E-mail: youdao@thepiacentegroup.com In the United States:

Original reporting
Published Aug 20, 2026, 10:47 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DAO
Bullish
high confidence
Mentioned
$DAO
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$DAOBullishHigh
01

Why it matters

The earnings release provides fresh data on revenue mix and profitability, influencing short‑term trading decisions.

02

Market read

First‑report earnings with profit swing and margin expansion make the article highly relevant for traders.

03

What to watch

Cash position remains limited; future guidance not provided.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Youdao (NYSE:DAO) is a Chinese AI solutions provider focusing on learning and advertising.

Company-level read

Ticker impact

$DAOBullishHigh confidence
Context

Youdao released its Q2 2026 unaudited earnings with revenue up 3.5% YoY and a swing to net profit.

Expected impact

Potential modest price rise on earnings surprise.

Evidence & confidence

First‑report earnings numbers show improved margins and a shift to profit, which traders can act on immediately.

Market effects

AI‑driven education and advertising services may see renewed investor interest.

Positive for Chinese tech stocks listed in the US.

Adds to broader AI sector momentum.

Counterpoint

Revenue growth is modest; smart‑device decline could signal broader demand weakness.

Key entities

  • Youdao, Inc.

    AI solutions provider reporting Q2 2026 results.

  • Dr. Feng Zhou

    CEO who commented on the quarter's performance.

Related articles

$DAOHigh

Youdao (DAO) Q2 2026 Earnings Call Transcript

Youdao (DAO) reported Q2 2026 revenue of RMB 1.5 billion, up 3.5% YoY. Learning services revenue grew 20.9%, while smart devices revenue fell 31.5%. Net income was RMB 73.8 million, reversing last year's loss. Management highlighted AI-driven growth and cost pressures in smart devices.

$DAOHighAI 8/10

Youdao shares rise as Q2 earnings beat offsets revenue shortfall

Youdao (NYSE: DAO) shares rose 1.86% premarket after Q2 earnings of RMB0.76 per ADS beat estimates, though revenue of RMB1.47B missed forecasts. Profitability improved with net income of RMB73.8M and gross margin expansion to 48.9%. Learning services revenue grew 20.9%, while smart devices and online marketing declined.

$DAOHighAI 8/10

Youdao Reports Second Quarter 2026 Unaudited Financial Results

Youdao (NYSE: DAO) reported Q2 2026 revenue of RMB1.5B (US$216.2M), up 3.5% YoY. Learning services revenue grew 20.9%, while smart devices and online marketing services declined 31.5% and 7.7%, respectively. Gross margin improved to 48.9% from 43.0%. Net income was RMB73.8M (US$10.9M), a turnaround from a loss in Q2 2025. CEO Dr. Feng Zhou highlighted sustainable growth and AI-driven progress.

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.